Comparing a Cream and Steroid Injection for Patchy Hair Loss
Treatments studied
Part of Skin clinical trials.
This study compares a cream (calcipotriol) with a steroid injection to treat patchy hair loss from alopecia areata. It aims to find which works better for people with mild to moderate scalp hair loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have patchy hair loss on your scalp (not total baldness or scarring).
- Less than half of your scalp is affected by hair loss.
- You have not used any treatment (creams, pills, or injections) for alopecia areata in the last 3 months.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two injections—triamcinolone (a steroid) and candida albicans antigen (a yeast extract)—to see which works better for alopecia areata (patchy hair loss). You might benefit if you have mild to moderate hair loss and haven't used other treatments recently.
This trial compares two creams—one with simvastatin (a cholesterol medicine) and one with a steroid—to see which works better for patchy hair loss caused by alopecia areata. It may help you if you have mild to moderate patchy hair loss and haven't used other treatments recently.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study tests if a cream containing methotrexate (a medicine that affects the immune system) can help regrow hair in people with mild alopecia areata (patchy hair loss on the scalp). It compares the methotrexate cream to a standard treatment cream (minoxidil) to see which works better.
This trial tests a new topical cream for people with patchy alopecia areata (a type of hair loss). It aims to help regrow hair without using stronger medicines.
This Phase 2 trial tests dupilumab (an injection medicine) to regrow hair in people with alopecia areata, a condition where the immune system attacks hair follicles. It may help by reducing the immune-related inflammation linked to hair loss.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.